The experiences of one doctor in Louisiana reveal the tensions around trying to get people to engage in addiction treatment, ...
Exenatide (Ex-4), a glucagonlike peptide-1 (GLP-1) receptor agonist currently used in the management of type 2 diabetes, could effectively treat drug addiction, including cocaine dependence, new ...
Ana Clara Bobadilla receives funding from the National Institute on Drug Abuse and the Brain & Behavior Research Foundation. Everyday human behavior is guided and shaped by the search for rewards.
There is an endless and overwhelming amount of information on the Web about addiction treatment options. Many people have no idea where to begin or what type of care that they or their loved one may ...
Dr. Nora Volkow, who leads the National Institutes of Drug Abuse, would like the public to know things are getting better. Mostly. By Matt Richtel Historically speaking, it’s not a bad time to be the ...
Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged. Beyond helping people shed pounds, they also lower the risk of heart ...
Ms. Szalavitz is a contributing Opinion writer who covers addiction and public policy. In late 2016, Steven Klein realized that he’d lost control over his drinking and stimulant use. He became sober ...
Experts say Biden's focus on addiction health care saved tens of thousands of lives and slowed fentanyl smuggling. Trump ...
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback